GET THE APP

Therapeutic Drugs Journals | Open Access Journals

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Submit Manuscript

Therapeutic Drugs Journals

Marine microorganisms widely distributed on our oceans of the earth and emerging as the great source for the discovery of natural products. Further they are developing as therapeutic agents for various human diseases. Antibacterial, antifungal, anti-parasitic, antiviral, anti-infective, insecticidal, antitumor, antiinflammatory, antioxidant and herbicidal compounds as well as many other compounds are enzyme inhibitors have been isolating from marine actinomycetes. Marine drugs have been used as therapeutic drug for various diseases like cancer, typhoid, cholera etc, Hymenialdisine (HMD), a sponge-derived natural product reported as human kinase inhibitors with nanomolar activity. Several antitumor antibiotics like aporphine alkaloids have been isolated from marine actinomycetes. Several marine-derived compounds used as anticancer agents are undergoing promising preclinical and clinical development. Therefore, the marinederivedactinomycetes act as a prominent reservoir for novel drug molecules and answer to several diseases. (NagendraSastryYarla, Marine Actinomycetes: A Source of Novel Therapeutic Drugs)

High Impact List of Articles

Young Research Forum ÃƒÂ¢Ã‚â‚¬Ã‚â€œ Young Scientist Awards: Pharma China 2020, November 16-17, 2020, Shanghai, China
Dr. Alice Geny
Awards 2021: Pharmaceutical Regulatory Affairs: Open Access
Young Research Forum ÃƒÂ¢Ã‚â‚¬Ã‚â€œ Young Scientist Awards: Pharma China 2020, November 16-17, 2020, Shanghai, China
Dr. Alice Geny
Awards 2021: Pharmaceutical Regulatory Affairs: Open Access
Awards of Pharmacovigilance and Clinical trials, March 16-17,2020 Sydney, Australia
Dr. Gerald Tan
Awards 2021: Pharmaceutical Regulatory Affairs: Open Access
Awards of Pharmacovigilance and Clinical trials, March 16-17,2020 Sydney, Australia
Dr. Gerald Tan
Awards 2021: Pharmaceutical Regulatory Affairs: Open Access
Role of Nutraceuticals as an Alternative Pharmaceutical for Medicinal & Health Benefits
Swarupananda M and Sohini B
Short Commentary: Pharmaceutical Regulatory Affairs: Open Access
Role of Nutraceuticals as an Alternative Pharmaceutical for Medicinal & Health Benefits
Swarupananda M and Sohini B
Short Commentary: Pharmaceutical Regulatory Affairs: Open Access
The Development of Medical Devices in Foreign Markets
Wang J and Giuffrida A
Commentary: Pharmaceutical Regulatory Affairs: Open Access
The Development of Medical Devices in Foreign Markets
Wang J and Giuffrida A
Commentary: Pharmaceutical Regulatory Affairs: Open Access
Malaysian Cosmetic Market: Current and Future Prospects
Mohamed Azmi Hassali
Mini Review: Pharmaceutical Regulatory Affairs: Open Access
Malaysian Cosmetic Market: Current and Future Prospects
Mohamed Azmi Hassali
Mini Review: Pharmaceutical Regulatory Affairs: Open Access

Conference Proceedings

Upstream bioprocessing of natural colchicine
Ganapathy Sivakumar
Keynote: Journal of Bioprocessing & Biotechniques
Upstream bioprocessing of natural colchicine
Ganapathy Sivakumar
Keynote: Journal of Bioprocessing & Biotechniques
Evolving biosimilars regulatory landscape: US and EU
Kamali Chance
Keynote: Journal of Bioanalysis & Biomedicine
Evolving biosimilars regulatory landscape: US and EU
Kamali Chance
Keynote: Journal of Bioanalysis & Biomedicine
Regulatory environment in the emerging markets: A focus on Middle East and North Africa in the emerging market region to highlight the recent updates in regulation and its shadow on future business in the region
Hany Gamal
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Regulatory environment in the emerging markets: A focus on Middle East and North Africa in the emerging market region to highlight the recent updates in regulation and its shadow on future business in the region
Hany Gamal
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Regulatory requirements of drug products for human use in EU & Turkey
Figen Kabadas
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Regulatory requirements of drug products for human use in EU & Turkey
Figen Kabadas
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
S-IMBPEH- Studies on the isolation, molecular identification, biochemical and physiological optimization of extremophilic halobacteria for the mass scale extraction of antibacterial carotenoids
A. Hyder Ali
Accepted Abstracts: Journal of Bioanalysis & Biomedicine
S-IMBPEH- Studies on the isolation, molecular identification, biochemical and physiological optimization of extremophilic halobacteria for the mass scale extraction of antibacterial carotenoids
A. Hyder Ali
Accepted Abstracts: Journal of Bioanalysis & Biomedicine

Relevant Topics in Pharmaceutical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

Related Links

Open Access Journals